In radiotherapy-resistant prostate cancer, a combination of FASN inhibition and radiotherapy decreased NF-kB activity and induced apoptosis [64], whereas in breast tumours, apoptosis was concomitant with pro-death BH3 family proteins BIM, PUMA, and NOXA [65]. Here, FASN is linked to prostate carcinoma.